Printer Friendly
The Free Library
14,680,804 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Panacea Pharmaceuticals, Inc. Appoints Vice President for Business Development and Director of Diagnostic Division.


Business Editors/Health & Medical Writers

BIOWIRE2K

ROCKVILLE, Md.--(BW HealthWire)--June 8, 2000

Panacea Pharmaceuticals, Inc. is pleased to announce that Alan H. Deutch, Ph.D., has joined Panacea as Vice President for Business Development and Director of the Diagnostic Division.

Dr. Deutch brings with him extensive experience and skills in intellectual property and technology licensing matters, business development, and the management of sponsored research programs. His thorough knowledge of global diagnostic markets positions Panacea's Diagnostic Division for rapid growth.

Dr. Deutch was most recently Director of Strategic Ventures and Licensing at Specialty Laboratories in Santa Monica, California For other uses, see Santa Monica (disambiguation).
Santa Monica is a coastal city in western Los Angeles County, California, USA. Situated on Santa Monica Bay of the Pacific Ocean, it is surrounded by the City of Los Angeles — Pacific Palisades and Brentwood on the north,
, a large privately-held international clinical diagnostic laboratory, where he was responsible for virtually all patent, freedom-to-operate, and technology licensing activities.

Prior to that, Dr. Deutch spent more than thirteen years at W. R. Grace & Company in their corporate research and development division, where he served as Senior Scientist and later as Department Head for the BioMolecular Research Department. Dr. Deutch also worked as Group Leader of the Microbial Genetics Microbial Genetics is a subject area within biotechnology and genetic engineering. It studies the genetics of very small (micro) organisms. This involves the study of the genotype of microbial species and also the expression system in the form of phenotypes.  Group at Bethesda Research Laboratories, Inc., which later became Life Technologies.

"We are delighted to have Alan join Panacea. His experience and record of achievement will provide an immediate impact in matters pertaining per·tain  
intr.v. per·tained, per·tain·ing, per·tains
1. To have reference; relate: evidence that pertains to the accident.

2.
 to licensing and development opportunities with existing and prospective partners," said Hossein A. Ghanbari, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Panacea. "Alan's expertise will enable us to aggressively pursue in-licensing opportunities for our Diagnostic Division."

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , brain tumors, transmissible spongiform encephalopathies Transmissible spongiform encephalopathies (TSEs, also known as prion diseases) are a group of progressive conditions that affect the brain and nervous system of humans and animals and are transmitted by prions. , and Lewy Body Lewy bodies are abnormal aggregates of protein that develop inside nerve cells. They are identified under the microscope when histology is performed on the brain.

Lewy bodies appear as spherical masses that displace other cell components.
 diseases such as Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. .

Changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation are utilized to develop diagnostic tests and therapeutic agents.

More information will soon be made available at www.PanaceaPharma.com, a web site developed by Ei Web Promotion, a subsidiary of eiCommunications.com, Inc. and a member of the eiCommunications.com Network (www.eiCommunications.com), which offers integrated communications and web development solutions for the Information Age.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 8, 2000
Words:347
Previous Article:UAL, AMR Corporate Brands Gain Altitude, But Still Trail Peers in Latest Airline Industry Study by Corporate Branding.
Next Article:Autonomy Announces Major ASP Partnership; Autonomy to supply technology to SMEs on ASP platform.



Related Articles
People in the News.
People in the News.
People in the News.
Panacea Pharmaceuticals, Inc. Announces Appointment of Several Key Management Positions to its Diagnostic Division.
People in the News.(hirings and promotions)(Brief Article)
Panacea Pharmaceuticals, Inc. Appoints Lawrence Glass as Senior Vice-President for Corporate Development.
Health care. (Newsmakers).(Brief Article)
Technology. (Newsmakers).(meshed briefs; new executives)(Brief Article)
Names in the news.(appointments)
Names in the news.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles